4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review

4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review

This systematic review summarizes the existing evidence on the effect of 4-aminopyridine (4-AP) as a symptomatic treatment of decreased walking capacity in patients with multiple sclerosis (MS) when administered as an immediate release compound and a slow release compound. It summarizes existing evi...

Full description

Bibliographic Details
Main Authors:	Henrik Boye Jensen, Mads Ravnborg, Ulrik Dalgas, Egon Stenager
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-03-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/1756285613512712

Similar Items

Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?
by: Ulrik Dalgas, et al.
Published: (2012-03-01)

Ontology for Symptomatic Treatment of Multiple Sclerosis
by: Misagh Zahiri Esfahani, et al.
Published: (2022-10-01)

Exercise training improves participation in persons with multiple sclerosis: A systematic review and meta-analysis
by: Thomas Edwards, et al.
Published: (2022-05-01)

The symptomatic management of multiple sclerosis
by: Schapiro Randall
Published: (2009-01-01)

Effects of Exercise Training on Neurotrophic Factors and Subsequent Neuroprotection in Persons with Multiple Sclerosis—A Systematic Review and Meta-Analysis
by: Mette D. Diechmann, et al.
Published: (2021-11-01)

Maternal Multiple Sclerosis and Health Outcomes Among the Children: A Systematic Review
by: Andersen ML, et al.
Published: (2023-03-01)

The combined deleterious effects of multiple sclerosis and ageing on neuromuscular function
by: Tobias Gaemelke, et al.
Published: (2023-12-01)

Quantification of the usage of symptomatic treatment in patients suffering from multiple sclerosis.
by: Erélido Hernández Valero, et al.
Published: (2007-08-01)

Shared decision-making in multiple sclerosis physical symptomatic care: a systematic review
by: Aliza Bitton Ben-Zacharia, et al.
Published: (2023-06-01)

Functional improvement in individuals with chronic spinal cord injury treated with 4-aminopyridine: A systematic review
by: Martin Paredes-Cruz, et al.
Published: (2022-11-01)

Hydroxyapatite and Silicon-Modified Hydroxyapatite as Drug Carriers for 4-Aminopyridine
by: Laura Marincaș, et al.
Published: (2021-09-01)

KCNA1 gain‐of‐function epileptic encephalopathy treated with 4‐aminopyridine
by: Peter Müller, et al.
Published: (2023-04-01)

4‐Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury
by: Kuang‐Ching Tseng, et al.
Published: (2016-12-01)

In vivo laser speckle contrast imaging of 4-aminopyridine- or pentylenetetrazole-induced seizures
by: Yuhling Wang, et al.
Published: (2023-09-01)

Synthesis and Fluorescent Properties of Aminopyridines and the Application in “Click and Probing”
by: Zongyang Li, et al.
Published: (2022-02-01)

Green Synthetic Methods for a Schiff Base from 2-Aminopyridine and 4-Ethoxybenzaldehyde
by: E. Ogbonda-Chukwu, et al.
Published: (2022-12-01)

Comparison of 2‑Aminopyridine and 4‑Thiopseudisocytosine PNA Nucleobases for Hoogsteen Recognition of Guanosine in RNA
by: Ilze Kumpina, et al.
Published: (2024-02-01)

High intensity training may reverse the fiber type specific decline in myogenic stem cells in multiple sclerosis patients
by: Jean eFarup, et al.
Published: (2016-05-01)

Performance Measures and Plasma Biomarker Levels in Patients with Multiple Sclerosis after 14 Days of Fampridine Treatment: An Explorative Study
by: Maria Thorning, et al.
Published: (2024-01-01)

PSEUDOTUMORAL FORM OF MULTIPLE SCLEROSIS WITH SYMPTOMATIC CONVULSIVE SEIZURES (A CLINICAL CASE)
by: Yu. A. Belova, et al.
Published: (2016-01-01)

4-Aminopyridine Induces Nerve Growth Factor to Improve Skin Wound Healing and Tissue Regeneration
by: Mashanipalya G. Jagadeeshaprasad, et al.
Published: (2022-07-01)

Synthesis, Structural Determination and Antibacterial Properties of Zinc(II) Complexes Containing 4-Aminopyridine Ligands
by: I Wayan Dasna, et al.
Published: (2023-08-01)

Treatments for fatigue in multiple sclerosis: A rapid and systematic review
by: Branas, P, et al.
Published: (2000)

Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
by: Brañas, P, et al.
Published: (2000)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
by: D. L. Klabukova, et al.
Published: (2018-07-01)

Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats
by: M. Sofiabadi, et al.
Published: (2015-06-01)

Synthesis of 2-aminopyridine Lactones and Studies of Their Antioxidant, Antibacterial and Antifungal Properties
by: Fadila Salhi, et al.
Published: (2021-11-01)

Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the “power training in older multiple sclerosis patients (PoTOMS) randomized control trial
by: Tobias Gaemelke, et al.
Published: (2024-04-01)

MS mortality.
by: Stenager, E, et al.
Published: (1992)

Defining pre-symptomatic amyotrophic lateral sclerosis
by: Benatar, M, et al.
Published: (2019)

Effectiveness of dry needling on the treatment of patients with multiple sclerosis: systematic review
by: Ali Mutlu, et al.
Published: (2023-12-01)

Investigation of the Protective Role of Quercetin on Oxidative Stress and Endoplasmic Stress Pathway in 4-aminopyridine-induced Neuronal Damage
by: Ahmet Taşkıran, et al.
Published: (2023-12-01)

Effect of ropivacaine combined with pancuronium on neuromuscular transmission and effectiveness of neostigmine and 4-aminopyridine for blockade reversal: experimental study
by: Angélica de Fátima Braga, et al.
Published: (2015-03-01)

Human cerebral spheroids undergo 4-aminopyridine-induced, activity associated changes in cellular composition and microrna expression
by: Thomas Parmentier, et al.
Published: (2022-06-01)

Treatment of multiple sclerosis.
by: Ebers, G
Published: (1994)

Treatment of multiple sclerosis
by: Pandit Lekha, et al.
Published: (2011-01-01)

4-aminopyridine improves evoked potentials and ambulation in the taiep rat: A model of hypomyelination with atrophy of basal ganglia and cerebellum.
by: Jose R Eguibar, et al.
Published: (2024-01-01)

New Solid Forms of Nitrofurantoin and 4-Aminopyridine Salt: Influence of Salt Hydration Level on Crystal Packing and Physicochemical Properties
by: Denis E. Boycov, et al.
Published: (2022-12-01)

4-Aminopyridine Improves Lower Urinary Tract Symptoms in a Patient With Benign Prostatic Hyperplasia and Downbeat Nystagmus Syndrome
by: Michael Strupp, et al.
Published: (2014-12-01)

KB-R7943 reduces 4-aminopyridine-induced epileptiform activity in adult rats after neuronal damage induced by neonatal monosodium glutamate treatment
by: Mariana Hernandez-Ojeda, et al.
Published: (2017-05-01)